These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28493098)

  • 1. Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care.
    Sadee W
    Pharm Res; 2017 Aug; 34(8):1535-1538. PubMed ID: 28493098
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
    La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
    Hizel HC
    Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

  • 6. Herbal Remedies: Throwing Off Phenotype Prediction-A Culprit for Pharmacogenomic-Guided Drug Therapy and Drug Safety.
    Dandara C; Thomford NE; Bapiro TE
    Clin Pharmacol Ther; 2019 Aug; 106(2):302-304. PubMed ID: 31245840
    [No Abstract]   [Full Text] [Related]  

  • 7. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PG-path: Modeling and personalizing pharmacogenomics-based pathways.
    Hong JY; Kim JH
    PLoS One; 2020; 15(5):e0230950. PubMed ID: 32365122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
    Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE
    Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517
    [No Abstract]   [Full Text] [Related]  

  • 11. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
    Harrison N
    Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 17. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
    Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetically tailored treatments for heart disease.
    Vafiadaki E; Arvanitis DA; Kranias EG; Sanoudou D
    Curr Pharm Des; 2010; 16(20):2194-213. PubMed ID: 20459385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
    LLerena A; Peñas-Lledó EM
    Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.